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Supplementary	  Figure	  S1	  |	  Expression	  and	  purification	  of	  recombinant	  α-­‐Syn	  protein.  
(a) Purification steps of  mouse (Mo α-Syn,) α-Syn protein. M: protein molecular weight 
markers; T0: whole-cell lysate from un-induced cells; T4: whole-cells lysate after 4 hours 
induction with 0.6 mM IPTG; Mo-Syn: purified α-Syn protein (mouse). (b) Mass 
spectrometry confirmed molecular masss of the protein (Mo α-Syn). (c) Lag phase of 
fibril formation for mouse α-Syn protein. The mouse α-Syn protein forms fibrils  fast(2.4 
± 0.23 hours). Data are presented as mean ± SD of three experiments, four replicas for 
each. (d) Fibrillation curve of recombinant mouse α-Syn protein with the time course of 
ThT changes. The red-blue arrows and square indicates the collection of short α-Syn 
fibrils, while the pink arrow shows the final time point for the collection of long α-Syn 
fibrils. (e) Western blot depicts the biochemical profile of short amyloid fibrils before and 
after 5 min sonication, together with long amyloid fibrils that were sonicated (Long α-
Syn fibrils sonicated). 
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Supplementary	   Figure	   S2	   |	  AFM	  analysis	   of	   different	  α-­‐Syn	   protein	   forms. (a) AFM 
images of monomeric and fibrillar α-Syn particles (grey monomeric, red non sonicated, 
blue sonicated). (b) Length quantification of fibrillar α-Syn before and after sonication 
process (red non sonicated, blue sonicated). Data are represented as mean ± SD. 
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Supplementary	   Figure	   S3	   |	   PrP	   and	   α-­‐Syn	   proteins	   after	   the	   incubation	   with	   non-­‐
sonicated	  and	  sonicated	  mouse	  α-­‐Syn	  fibrils. (a) Immunofluorescence of N2aPrP-/- cells 
transfected with full-length PrP (N2aPrPFL, green) shows the co-localization with the 
exogenously added α-Syn amyloid fibrils (red) on the cell membrane. Scale bar 15 µm. 
(b) Western blots depict PrPC and α-Syn protein levels after treatment with α-Syn 
amyloid preparations. Each line was loaded with 30 µg of total protein. β-Actin was used 
as a loading control.  
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Supplementary	   Figure	   S4	   |	   Effect	   of	  mouse	  α-­‐Syn	  preparations	  on	   endogenous	  PrPC	  
and	  transfected	  PrPFL	  protein	  levels	  in	  N2a	  cells. (a) The cell lysates of N2a PrP+/+ cells 
and (b) transfected N2aPrPFL cells were prepared as described in Materials and Methods 
and analyzed by SDS-PAGE and WB, using W226 anti-PrP antibody. Red and blue 
arrows at P0 indicate the treatment with non-sonicated and sonicated α-Syn amyloid 
fibrils, respectively). Each line was loaded with 30 µg of total protein. Lower graphs 
show the quantification of three independent experiments, after treatment with non-
sonicated α-Syn amyloids (red columns) and sonicated α-Syn amyloids (blue columns). 
The values are shown as a percentage of total PrP relative to actin. Data are represented 
as mean ± SD. Data were evaluated by unpaired t-test. Statistical analysis is indicated as: 
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* P < 0.05, ** P < 0.01, *** P < 0.001. (c) RT-PCR analysis of N2a non-treated and 
treated samples. ΔCT values for Prnp gene shows no variability among control and α-Syn 
treated samples. Normalization of RT-qPCR data was performed on two housekeeping 
genes, ACTB (empty column) and GAPDH (diagonal brick pattern). 
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Supplementary	   Figure	   S5	   |	   In	   Vitro	   cell	   cytotoxicity. Effect of different α-Syn forms 
(monomeric and fibrils) on growth of N2a PrP+/+, N2a PrP-/-, ScN2a cells measured by 
the MTT assay. Data are shown as mean ± SD of three separate experiments, each 
performed in six replicates.  
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Supplementary	  Figure	  S6	  |	  Detection	  of	  	  α-­‐Syn	  fibrils	  	  in	  cellular	  compartments	  by	  
immunofluorescence	  in	  N2a	  PrP-­‐/-­‐	  cells.	  Confocal quadruple-labeled immunofluorescent 
images on N2a PrP-/- cells show the localization of the α-Syn fibrils (red) outside the 
cells. Other cellular compartments were investigated (EE1, early endosome; Calnexin, 
endoplasmatic reticulum; LAMP1, lysosomes; Mannose 6 Phosphate Receptor-M6PR, 
Golgi apparatus). Scale bars 10 µm. 
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Supplementary	  Figure	  S7	  |	  Detection	  of	  	  α-­‐Syn	  fibrils	  	  in	  cellular	  compartments	  by	  
immunofluorescence	  in	  N2a	  PrP+/+	  cells. Confocal quadruple-labeled immunofluorescent 
images on N2a PrP+/+ cells show the localization of the α-Syn fibrils (red) in the 
lysosomal compartments (LAMP1, cyan). Other cellular compartments were investigated 
(EE1, early endosome; Calnexin, endoplasmatic reticulum; Mannose 6 Phosphate 
Receptor-M6PR, Golgi apparatus). Scale bars 10 µm.  
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Supplementary	   Figure	   S8	   |	   Recombinant	   PrP	   protein	   binds	   α-­‐Syn	   amyloids. (a) 
Western blot of recombinant full-length and truncated PrP protein (MoPrP(23-231) and 
MoPrP(89-231));  (b and c)  ELISA plates were precoated with 50 ng of recPrP and three 
different ratios of different forms α-Syn (1:1, 1:3, 1:10) were incubated for 30 min at 37 
°C. Values are given as mean ± SD. 
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Supplementary	   Figure	   S9	   |	   Binding	   of	   monomeric	   and	   fibrillar	   α-­‐Syn	   particles	   to	  
immobilized	  sonicated	  α-­‐Syn	  fibrils	  on	  CM5	  biosensor	  chip. (a) Addition of monomeric 
α-Syn to sonicated α-Syn amyloid surfaces. Three different densities (3300, 4100, and 
5000 RU) of sonicated α-Syn amyloid fibrils were immobilized in separate flow cells. 
Monomeric α-Syn was injected at a concentration of 3 µM over the biosensor chip for 3 
min at 50 µL/min association phase) and afterwards flushing with running buffer 
(dissociation phase). Figure Shows the interaction with monomeric α-Syn as a positive 
control.  (b) SPR sensogram shows MoPrP(23-231) binding to α-Syn amyloid fibrils 
immobilized on CM5 biosensor chip. After the immobilization, soluble recombinant full-
length MoPrP (100 nM) was injected across the biosensor chip (binding phase) followed 
by the injection of buffer alone (dissociation phase). The sensogram showed that the full-
length MoPrP binds to the sonicated α-Syn amyloid fibrils. Association and dissociation 
phases of full-length MoPrP interaction with sonicated α-Syn amyloid fibrils were 
elaborated using double referencing and analyzed separately: the association phase was 
fitted with a single exponential equation, determining a unique value of kon; the 
dissociation phase was analyzed with a double exponential equation, since the sensogram 
was more adequately fitted by a biphasic model (significantly improved error 
parameters). The included table indicates the KD values calculated using the formula 
KD=Kon/Koff. 
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Supplementary	   Figure	   S10	   |	   Altered	   hindlimb	   clasping	   behavior	   in	  Prnp+/+	  mice	   and	  
normal	   behavior	   in	   Prnp-­‐/-­‐	   mice. Example of hindlimb clasping: hindlimb clasping 
behavior towards the abdomen in Prnp+/+ mice, and hindlimbs splayed outwards away 
from abdomen in Prnp-/- mice like in control mice. 
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Supplementary	  Figure	  S11	  |	   	   Immunofluorescence	  (IF)	  analysis	  of	  ScN2a	  cells	  treated	  
with	  α-­‐Syn	  amyloids	   show	  decreased	   levels	  of	  PrPSc. Denaturation with 6 M GdnHCl 
permits the detection of PrPSc in ScN2a cells by IF (ctrl). Cells treated with α-Syn 
amyloids do not show PrPSc deposits following the denaturation with 6M GndHCl. Scale 
bars 15 µm. 
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Supplementary	   Figure	   S12	   |	   Characterization	  of	   human	  α-­‐Syn	   fibrils. (a) Purification 
steps of human (Hu α-Syn,) α-Syn protein. M: protein molecular weight markers; T0: 
whole-cell lysate from un-induced cells; T4: whole-cells lysate after 4 hours induction 
with 0.6 mM IPTG; Hu-Syn: purified α-Syn protein (human). (b) Mass spectrometry 
confirmed molecular masss of the protein (Hu α-Syn). (c) Fibrillation assay of human 
WT, and three PD-associated mutants (A30P, E46K, and A53T) show different lag 
phases of fibril formation. (d) Western blot of human WT, A30P, E46K, and A53T fibrils 
shows the migration of all species present in the sample. (e) AFM images of human α-
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Syn fibrillary species and (f) corresponding quantification of length and height. Data are 
shown as mean ± SD.  
 
 
Supplementary	   Figure	   S13	   |	   Mass	   spectroscopy	   of	   human	  WT	   α-­‐Syn	   and	   three	   PD	  
associated	  mutants	  (A30P,	  E46K	  and	  A53T). The molecular weight of WT, A30P, E46K 
and A53T measured are 14460.7, 14486.2, 14459.0, 14490.3 Da respectively, while those 
theorical predicted 14460.2, 14486.2, 14459.2, 14490.2 Da 
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Supplementary	   Figure	  S14	  |	   In	   vitro	   effect	  of	  human	  α-­‐Syn	   species	   (monomeric	   and	  
fibrillary)	   on	   cells. (a) Effect of different human α-Syn forms (WT, A30P, E46K and 
A53T, monomers and fibrils) on growth of N2a PrP+/+, N2a PrP-/-, ScN2a cells measured 
by the MTT assay. Data are shown as mean±SD of three separate experiments, each 
performed in six replicates. Statistical significance was determined by using unpaired t-
test. Statistical analysis is indicated as: * P < 0.05, ** P < 0.01. (b) Immunoblots of 
ScN2a lysates after treatment for four days with monomeric and fibrillar human α-Syn 
forms, without (-) and with (+) Proteinase K (PK) digestion. High exposure shows that 
the treatment with α-Syn fibrils increases the production of C1 fragment. (c) 
Quantification of (b), n=3 independent experiments. Values are given as mean ± SD. 
Statistical significance was determined by using unpaired t-test. Statistical analysis is 
indicated as: * P < 0.05, ** P < 0.01, *** P < 0.001. 
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Supplementary	   Figure	   S15	   |	   Production	   and	   biochemical	   characterization	   of	   tau	  
fragment	   (K18). (a) Purification steps of human tau fragment (K18). MWL: protein 
molecular weight markers; no-IPTG: whole-cell lysate from un-induced cells; IPTG: 
whole-cells lysate after induction with 0.5 mM IPTG; Lysate no boiling - Lysates before 
boiling, P-pellet, S-supernatant; Lysate boiling - Lysates after boiling, P-pellet, S-
supernatant; (b, and c) Cation exchange chromatography fraction collection. (d) 
Fibrillation of tau fragment (fibrillation condition: 0.5 mg/mL tau protein, 50 µg/mL 
heparin, 0.1 mM DTT in PBS pH 7.4. 10 µM ThT). AFM (e) and SEM (f) images of 
fibrillar tau fragment K18. 
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Supplementary	   Figure	   S16	   |	   Amyloid-­‐β	   and	   tau	   fragment	   K18. (a) Western blots of 
amyloid-β and tau fragment K18 in their fibrillary forms show migration of different 
forms (aggregates, oligomers and monomers).  (b) Effect of Amyloid-β and tau fragment 
K18 on growth of N2a PrP+/+, N2a PrP-/-, ScN2a cells measured by the MTT assay. Data 
are shown as mean±SD of three separate experiments, each performed in six replicates. 
Statistical significance was determined by using unpaired t-test. Statistical analysis is 
indicated as: * P < 0.05, ** P < 0.01, *** P < 0.001. (c) Immunoblots of ScN2a lysates 
after treatment for four days with Amyloid-β and tau fragment K18 fibrils, without (-) 
and with (+) Proteinase K (PK) digestion. (d) Quantification of (c), n=3 independent 
experiments. Values are given as mean ± SD. Statistical significance was determined by 
using unpaired t-test. Statistical analysis is indicated as: * P < 0.05, ** P < 0.01, *** P < 
0.001. (e) High exposure of the Western blot shown in (c) (non-digested with PK(-)), 
shows that the treatment with K18 fibrils increases the production of C1 fragment. (f) C1 
production in ScN2a cells was confirmed after PNGase F digestion when the membranes 
were probed with two antibodies (W226 is a C-terminal Ab, SAF34 is N-terminal Ab).  
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Supplementary	  Figure	  S17	  |	  Analysis	  of	  the	  length	  of	  the	  lag-­‐phase	  of	  amyloid	  seeding	  
assay	  curves	  of	  recPrP	  protein	  in	  the	  presence	  of	  various	  amyloid	  seeds. (a) The effect 
of adding various amyloids in the presence of full-length moPrP23-231 protein: the 
addition of PrPSc seed confirmed the shortening of the lag phase; Amyloid β, K18 tau 
fragment (non sonicated and sonicated fibrils), and monomeric α-Syn did not had any 
effect of the process of fibril formation of moPrP23-231 protein (same lag phase as 
control condition); all fibrillar forms of mouse α-Syn delayed the lag phase of fibril 
formation of the full-length moPrP23-231 protein. Data are reported as the mean ± SD of 
triplicate experiments. (b) The effect of adding various amyloids in the presence of 
truncated moPrP89-231 protein: the addition of PrPSc seed confirmed the shortening of 
the lag phase; K18 tau fragment (non sonicated and sonicated fibrils) did not had any 
effect of the process of fibril formation of moPrP89-231 protein (same lag phase as 
control condition); all fibrillar forms of mouse α-Syn, amyloid β, and monomeric α-Syn 
delayed the lag phase of fibril formation of the full-length moPrP89-231 protein. Data are 
reported as the mean ± SD of triplicate experiments. 
